ClinicalTrials.gov record
Terminated Phase 1 Interventional

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

ClinicalTrials.gov ID: NCT00023634

Public ClinicalTrials.gov record NCT00023634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Early Phase Study of an EGFRvIII Peptide Based Vaccine in Patients With EGFRvIII Expressing Cancers

Study identification

NCT ID
NCT00023634
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
14 participants

Conditions and interventions

Interventions

  • GMCSF Biological
  • KLH Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2001
Primary completion
Oct 31, 2008
Completion
Oct 31, 2008
Last update posted
Mar 5, 2015

2001 – 2008

United States locations

U.S. sites
13
U.S. states
2
U.S. cities
9
Facility City State ZIP Site status
Bay Regional Medical Center Bay City Michigan 48708
Mercy Regional Cancer Center at Mercy Hospital Port Huron Michigan 48060
St. Joseph Hospital Community Cancer Center Bellingham Washington 98225
Olympic Hematology and Oncology Bremerton Washington 98310
Skagit Valley Hospital Cancer Care Center Mount Vernon Washington 98273
Fred Hutchinson Cancer Research Center Seattle Washington 98104
Harborview Medical Center Seattle Washington 98104
Group Health Central Hospital Seattle Washington 98112
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98114
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043
North Puget Oncology at United General Hospital Sedro-Woolley Washington 98284
Cancer Care Northwest - Spokane South Spokane Washington 99202
Wenatchee Valley Clinic Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00023634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2015 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00023634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →